ANDA 202610, held by Thepharmanetwork LLC. Isoniazid.
As of Nov 15, 2026, ANDA 202610 (Isoniazid), held by Thepharmanetwork LLC, was first approved by FDA on Oct 29, 2014, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 29, 2014 | Original application | Approved | None posted |
| Feb 5, 2025 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 29, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
